Global Healthcare CMO Market (2019-2023 Edition)

Scope of the Report

The report entitled “Global Healthcare CMO Market (2019-2023 Edition)” provides a detailed analysis global healthcare CMO market with market sizing and growth. The analysis includes market size in terms of value, and market share by segments. A comprehensive segment analysis has also been provided in the report with their historical and forecasted value.

This report also provides the analysis of global pharmaceutical CDMO market. This analysis includes the global pharmaceutical CDMO market by value, and by geography. The regional analysis of global pharmaceutical CDMO market is also done in this report. The regions included are United States of America, Europe, China and India.

Company profiling of major players of healthcare CMO industry such as Catalent Pharma Solution, Recipharm, Aurobindo Pharma Ltd. and Boehringher Ingelheim has been done in the report. This segment of the report provides business overview, financial overview, and business strategies adopted by the respective companies.

Company Coverage

Catalent Pharma Solution
Recipharm
Aurobindo Pharma Ltd.
Boehringher Ingelheim

Regional Coverage

The US
Europe
India
China

Executive Summary

An outsourcing in which a pharmaceutical firm contacts with a third party (contract manufacturing organization) for the manufacturing of components of its product or whole of its product is known as contract manufacturing. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm.

A firm either big or mid-size selects a CMO for primarily two reasons: it wants to shift (or cut) its cost and focus to its core activities, or the development of its products require special or expert handling.

CMOs provide independent manufacturing services in healthcare sector also. Healthcare CMOs can be segmented into pharmaceutical CMOs and medical device CMOs. After the discovery of chemical formula of a new drug, the pharmaceutical CMOs are given the task of manufacturing it into a whole product, so that the pharmaceutical companies are able to sell it into the market under their brand name. Services offered by pharmaceutical CMOs can be divided into two main activities: primary manufacturing (Active Pharmaceutical Ingredients) and secondary manufacturing (Finished Dosage Formulation). Contract manufacturing for medical devices is one of the fastest growing segments of the medical device industry, as companies are in the race to bring new devices to the market.

The global healthcare CMO market has recorded continuous growth over the past few years and is expected to follow the same trend in coming years. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvals and outsourcing of NMEs, innovations and increased regulatory pressure on quality. Yet there are some challenges, which healthcare CMO industry faces, such as fragmented nature of market, less preference for outsourcing of profitable and biological drugs by big pharmaceutical companies.

Tags :

Figure 1: Healthcare CMOs Market Segments
Figure 2: Pharmaceutical Outsourcing Market Segments
Figure 3: Value Chain of a Drug
Figure 4: Global Healthcare CMO Market by Value; 2014-2018 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Value; 2019-2023E (US$ Billion)
Figure 6: Global Healthcare CMO Market by Segments; 2018
Figure 7: Global Medical Device CMO Market by Value; 2014-2018 (US$ Billion)
Figure 8: Global Medical Device CMO Market by Value; 2019-2023E (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Value; 2014-2018 (US$ Billion)
Figure 10: Global Pharmaceutical CMO Market by Value; 2019-2023E (US$ Billion)
Figure 11: Global Pharmaceutical CMO Market by Segments; 2018
Figure 12: Global Pharmaceutical CMO Market by Region; 2017
Figure 13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2017-2018 (US$ Billion)
Figure 14: Global Active Pharmaceutical Ingredient CMO Market by Value; 2019-2023 (US$ Billion)
Figure 15: Global Finished Dosage Formulation CMO Market by Value; 2017-2018 (US$ Billion)
Figure 16: Global Finished Dosage Formulation CMO Market by Value; 2019-2023E (US$ Billion)
Figure 17: Global Other Pharmaceutical Services CMO Market by Value; 2017-2018 (US$ Billion)
Figure 18: Global Other Pharmaceutical Services CMO Market by Value; 2019-2023E (US$ Billion)
Figure 19: Global Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 20: Global Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 21: Global Pharmaceutical CDMO Market by Region; 2018
Figure 22: The U.S. Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 23: The U.S. Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 24: Europe Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 25: Europe Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 26: India Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 27: India Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 28: China Pharmaceutical CDMO Market by Value; 2014-2018 (US$ Billion)
Figure 29: China Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Figure 30: Catalent Revenue; 2014-2018 (US$ Billion)
Figure 31: Catalent, Inc. Revenue by Segments; 2018
Figure 32: Recipharm Net Sales; 2014-2018 (US$ Million)
Figure 33: Recipharm Net Sales by Segments; 2018
Figure 34: Recipharm Net Sales by Region; 2017
Figure 35: Aurobindo Revenues; 2014-2018 (US$ Billion)
Figure 36: Aurobindo Revenues by Segments; 2018
Figure 37: Boehringher Ingelheim Net Sales; 2013-2017 (US$ Billion)
Figure 38: Boehringher Ingelheim Net Sales by Geography; 2017
Figure 39: Boehringher Ingelheim Net Sales by Business; 2017
Table 1: Global Healthcare CMO Market Players Financial Comparison; 2017-2018